{
    "Trade/Device Name(s)": [
        "CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel, Influenza A Subtyping Kit (Ver4)",
        "Influenza A Subtyping Kit"
    ],
    "Submitter Information": "Centers for Disease Control and Prevention",
    "510(k) Number": "K241110",
    "Predicate Device Reference 510(k) Number(s)": [
        "K200370"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OZE",
        "NSU",
        "NXD",
        "OEP",
        "OOI",
        "OQW"
    ],
    "Summary Letter Date": "April 22, 2024",
    "Summary Letter Received Date": "April 22, 2024",
    "Submission Date": "April 16, 2024",
    "Regulation Number(s)": [
        "21 CFR 866.3980"
    ],
    "Regulation Name(s)": [
        "Respiratory Viral Panel Multiplex Nucleic Acid Assay"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "Influenza A virus RNA",
        "Influenza A(H3)",
        "Influenza A(H1)pdm09"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swab",
        "Nasal swab",
        "Throat swab",
        "Nasal aspirate",
        "Nasal wash",
        "Dual nasopharyngeal/throat swab",
        "Bronchoalveolar lavage",
        "Bronchial wash",
        "Tracheal aspirate",
        "Sputum",
        "Lung tissue",
        "Viral culture"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "FDA-cleared in vitro diagnostic real-time PCR instrument",
        "Applied Biosystems 7500 Fast Dx"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time RT-PCR",
        "Oligonucleotide primers and hydrolysis probes"
    ],
    "Methodologies": [
        "RT-PCR",
        "Molecular detection",
        "Multiplex nucleic acid assay"
    ],
    "Submission Type(s)": [
        "Kit",
        "Panel",
        "Reagent",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel, Influenza A Subtyping Kit (Ver4) for detection and subtyping of human influenza A viruses.",
    "Indications for Use Summary": "Intended for determination of the subtype of seasonal human influenza A viruses as A(H3) and/or A(H1)pdm09 from viral RNA in respiratory specimens and viral cultures, and to provide epidemiologic information for influenza surveillance.",
    "fda_folder": "Microbiology"
}